Global Age Related Macular Degeneration (AMD) Market Research Report 2023

Report ID: 1982931 | Published Date: Jan 2025 | No. of Page: 81 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Age Related Macular Degeneration (AMD) Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Wet AMD
        1.2.3 Dry AMD
    1.3 Market by Application
        1.3.1 Global Age Related Macular Degeneration (AMD) Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Men
        1.3.3 Woman
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Age Related Macular Degeneration (AMD) Market Perspective (2017-2028)
    2.2 Age Related Macular Degeneration (AMD) Growth Trends by Region
        2.2.1 Age Related Macular Degeneration (AMD) Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Age Related Macular Degeneration (AMD) Historic Market Size by Region (2017-2022)
        2.2.3 Age Related Macular Degeneration (AMD) Forecasted Market Size by Region (2023-2028)
    2.3 Age Related Macular Degeneration (AMD) Market Dynamics
        2.3.1 Age Related Macular Degeneration (AMD) Industry Trends
        2.3.2 Age Related Macular Degeneration (AMD) Market Drivers
        2.3.3 Age Related Macular Degeneration (AMD) Market Challenges
        2.3.4 Age Related Macular Degeneration (AMD) Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Age Related Macular Degeneration (AMD) Players by Revenue
        3.1.1 Global Top Age Related Macular Degeneration (AMD) Players by Revenue (2017-2022)
        3.1.2 Global Age Related Macular Degeneration (AMD) Revenue Market Share by Players (2017-2022)
    3.2 Global Age Related Macular Degeneration (AMD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Age Related Macular Degeneration (AMD) Revenue
    3.4 Global Age Related Macular Degeneration (AMD) Market Concentration Ratio
        3.4.1 Global Age Related Macular Degeneration (AMD) Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Age Related Macular Degeneration (AMD) Revenue in 2021
    3.5 Age Related Macular Degeneration (AMD) Key Players Head office and Area Served
    3.6 Key Players Age Related Macular Degeneration (AMD) Product Solution and Service
    3.7 Date of Enter into Age Related Macular Degeneration (AMD) Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Age Related Macular Degeneration (AMD) Breakdown Data by Type
    4.1 Global Age Related Macular Degeneration (AMD) Historic Market Size by Type (2017-2022)
    4.2 Global Age Related Macular Degeneration (AMD) Forecasted Market Size by Type (2023-2028)
5 Age Related Macular Degeneration (AMD) Breakdown Data by Application
    5.1 Global Age Related Macular Degeneration (AMD) Historic Market Size by Application (2017-2022)
    5.2 Global Age Related Macular Degeneration (AMD) Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Age Related Macular Degeneration (AMD) Market Size (2017-2028)
    6.2 North America Age Related Macular Degeneration (AMD) Market Size by Country (2017-2022)
    6.3 North America Age Related Macular Degeneration (AMD) Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Age Related Macular Degeneration (AMD) Market Size (2017-2028)
    7.2 Europe Age Related Macular Degeneration (AMD) Market Size by Country (2017-2022)
    7.3 Europe Age Related Macular Degeneration (AMD) Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Age Related Macular Degeneration (AMD) Market Size (2017-2028)
    8.2 Asia-Pacific Age Related Macular Degeneration (AMD) Market Size by Country (2017-2022)
    8.3 Asia-Pacific Age Related Macular Degeneration (AMD) Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Age Related Macular Degeneration (AMD) Market Size (2017-2028)
    9.2 Latin America Age Related Macular Degeneration (AMD) Market Size by Country (2017-2022)
    9.3 Latin America Age Related Macular Degeneration (AMD) Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Age Related Macular Degeneration (AMD) Market Size (2017-2028)
    10.2 Middle East & Africa Age Related Macular Degeneration (AMD) Market Size by Country (2017-2022)
    10.3 Middle East & Africa Age Related Macular Degeneration (AMD) Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Bayer
        11.1.1 Bayer Company Detail
        11.1.2 Bayer Business Overview
        11.1.3 Bayer Age Related Macular Degeneration (AMD) Introduction
        11.1.4 Bayer Revenue in Age Related Macular Degeneration (AMD) Business (2017-2022)
        11.1.5 Bayer Recent Development
    11.2 F. HoffmannLa Roche
        11.2.1 F. HoffmannLa Roche Company Detail
        11.2.2 F. HoffmannLa Roche Business Overview
        11.2.3 F. HoffmannLa Roche Age Related Macular Degeneration (AMD) Introduction
        11.2.4 F. HoffmannLa Roche Revenue in Age Related Macular Degeneration (AMD) Business (2017-2022)
        11.2.5 F. HoffmannLa Roche Recent Development
    11.3 Regeneron
        11.3.1 Regeneron Company Detail
        11.3.2 Regeneron Business Overview
        11.3.3 Regeneron Age Related Macular Degeneration (AMD) Introduction
        11.3.4 Regeneron Revenue in Age Related Macular Degeneration (AMD) Business (2017-2022)
        11.3.5 Regeneron Recent Development
    11.4 Novartis
        11.4.1 Novartis Company Detail
        11.4.2 Novartis Business Overview
        11.4.3 Novartis Age Related Macular Degeneration (AMD) Introduction
        11.4.4 Novartis Revenue in Age Related Macular Degeneration (AMD) Business (2017-2022)
        11.4.5 Novartis Recent Development
    11.5 Valeant
        11.5.1 Valeant Company Detail
        11.5.2 Valeant Business Overview
        11.5.3 Valeant Age Related Macular Degeneration (AMD) Introduction
        11.5.4 Valeant Revenue in Age Related Macular Degeneration (AMD) Business (2017-2022)
        11.5.5 Valeant Recent Development
    11.6 Pfizer
        11.6.1 Pfizer Company Detail
        11.6.2 Pfizer Business Overview
        11.6.3 Pfizer Age Related Macular Degeneration (AMD) Introduction
        11.6.4 Pfizer Revenue in Age Related Macular Degeneration (AMD) Business (2017-2022)
        11.6.5 Pfizer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Age Related Macular Degeneration (AMD) Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Wet AMD
    Table 3. Key Players of Dry AMD
    Table 4. Global Age Related Macular Degeneration (AMD) Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Age Related Macular Degeneration (AMD) Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Age Related Macular Degeneration (AMD) Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Age Related Macular Degeneration (AMD) Market Share by Region (2017-2022)
    Table 8. Global Age Related Macular Degeneration (AMD) Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Age Related Macular Degeneration (AMD) Market Share by Region (2023-2028)
    Table 10. Age Related Macular Degeneration (AMD) Market Trends
    Table 11. Age Related Macular Degeneration (AMD) Market Drivers
    Table 12. Age Related Macular Degeneration (AMD) Market Challenges
    Table 13. Age Related Macular Degeneration (AMD) Market Restraints
    Table 14. Global Age Related Macular Degeneration (AMD) Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Age Related Macular Degeneration (AMD) Market Share by Players (2017-2022)
    Table 16. Global Top Age Related Macular Degeneration (AMD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Age Related Macular Degeneration (AMD) as of 2021)
    Table 17. Ranking of Global Top Age Related Macular Degeneration (AMD) Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Age Related Macular Degeneration (AMD) Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Age Related Macular Degeneration (AMD) Product Solution and Service
    Table 21. Date of Enter into Age Related Macular Degeneration (AMD) Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Age Related Macular Degeneration (AMD) Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Age Related Macular Degeneration (AMD) Revenue Market Share by Type (2017-2022)
    Table 25. Global Age Related Macular Degeneration (AMD) Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Age Related Macular Degeneration (AMD) Revenue Market Share by Type (2023-2028)
    Table 27. Global Age Related Macular Degeneration (AMD) Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Age Related Macular Degeneration (AMD) Revenue Market Share by Application (2017-2022)
    Table 29. Global Age Related Macular Degeneration (AMD) Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Age Related Macular Degeneration (AMD) Revenue Market Share by Application (2023-2028)
    Table 31. North America Age Related Macular Degeneration (AMD) Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Age Related Macular Degeneration (AMD) Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Age Related Macular Degeneration (AMD) Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Age Related Macular Degeneration (AMD) Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Age Related Macular Degeneration (AMD) Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Age Related Macular Degeneration (AMD) Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Age Related Macular Degeneration (AMD) Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Age Related Macular Degeneration (AMD) Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Age Related Macular Degeneration (AMD) Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Age Related Macular Degeneration (AMD) Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Bayer Company Detail
    Table 42. Bayer Business Overview
    Table 43. Bayer Age Related Macular Degeneration (AMD) Product
    Table 44. Bayer Revenue in Age Related Macular Degeneration (AMD) Business (2017-2022) & (US$ Million)
    Table 45. Bayer Recent Development
    Table 46. F. HoffmannLa Roche Company Detail
    Table 47. F. HoffmannLa Roche Business Overview
    Table 48. F. HoffmannLa Roche Age Related Macular Degeneration (AMD) Product
    Table 49. F. HoffmannLa Roche Revenue in Age Related Macular Degeneration (AMD) Business (2017-2022) & (US$ Million)
    Table 50. F. HoffmannLa Roche Recent Development
    Table 51. Regeneron Company Detail
    Table 52. Regeneron Business Overview
    Table 53. Regeneron Age Related Macular Degeneration (AMD) Product
    Table 54. Regeneron Revenue in Age Related Macular Degeneration (AMD) Business (2017-2022) & (US$ Million)
    Table 55. Regeneron Recent Development
    Table 56. Novartis Company Detail
    Table 57. Novartis Business Overview
    Table 58. Novartis Age Related Macular Degeneration (AMD) Product
    Table 59. Novartis Revenue in Age Related Macular Degeneration (AMD) Business (2017-2022) & (US$ Million)
    Table 60. Novartis Recent Development
    Table 61. Valeant Company Detail
    Table 62. Valeant Business Overview
    Table 63. Valeant Age Related Macular Degeneration (AMD) Product
    Table 64. Valeant Revenue in Age Related Macular Degeneration (AMD) Business (2017-2022) & (US$ Million)
    Table 65. Valeant Recent Development
    Table 66. Pfizer Company Detail
    Table 67. Pfizer Business Overview
    Table 68. Pfizer Age Related Macular Degeneration (AMD) Product
    Table 69. Pfizer Revenue in Age Related Macular Degeneration (AMD) Business (2017-2022) & (US$ Million)
    Table 70. Pfizer Recent Development
    Table 71. Research Programs/Design for This Report
    Table 72. Key Data Information from Secondary Sources
    Table 73. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Age Related Macular Degeneration (AMD) Market Share by Type: 2021 VS 2028
    Figure 2. Wet AMD Features
    Figure 3. Dry AMD Features
    Figure 4. Global Age Related Macular Degeneration (AMD) Market Share by Application in 2021 & 2028
    Figure 5. Men Case Studies
    Figure 6. Woman Case Studies
    Figure 7. Age Related Macular Degeneration (AMD) Report Years Considered
    Figure 8. Global Age Related Macular Degeneration (AMD) Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 9. Global Age Related Macular Degeneration (AMD) Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 10. Global Age Related Macular Degeneration (AMD) Market Share by Region: 2021 VS 2028
    Figure 11. Global Age Related Macular Degeneration (AMD) Market Share by Players in 2021
    Figure 12. Global Top Age Related Macular Degeneration (AMD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Age Related Macular Degeneration (AMD) as of 2021)
    Figure 13. The Top 10 and 5 Players Market Share by Age Related Macular Degeneration (AMD) Revenue in 2021
    Figure 14. North America Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 15. North America Age Related Macular Degeneration (AMD) Market Share by Country (2017-2028)
    Figure 16. United States Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 17. Canada Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Europe Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe Age Related Macular Degeneration (AMD) Market Share by Country (2017-2028)
    Figure 20. Germany Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. France Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. U.K. Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Italy Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Russia Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Nordic Countries Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Asia-Pacific Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Age Related Macular Degeneration (AMD) Market Share by Region (2017-2028)
    Figure 28. China Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Japan Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. South Korea Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Southeast Asia Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. India Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Australia Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Latin America Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America Age Related Macular Degeneration (AMD) Market Share by Country (2017-2028)
    Figure 36. Mexico Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Brazil Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Middle East & Africa Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa Age Related Macular Degeneration (AMD) Market Share by Country (2017-2028)
    Figure 40. Turkey Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Saudi Arabia Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Bayer Revenue Growth Rate in Age Related Macular Degeneration (AMD) Business (2017-2022)
    Figure 43. F. HoffmannLa Roche Revenue Growth Rate in Age Related Macular Degeneration (AMD) Business (2017-2022)
    Figure 44. Regeneron Revenue Growth Rate in Age Related Macular Degeneration (AMD) Business (2017-2022)
    Figure 45. Novartis Revenue Growth Rate in Age Related Macular Degeneration (AMD) Business (2017-2022)
    Figure 46. Valeant Revenue Growth Rate in Age Related Macular Degeneration (AMD) Business (2017-2022)
    Figure 47. Pfizer Revenue Growth Rate in Age Related Macular Degeneration (AMD) Business (2017-2022)
    Figure 48. Bottom-up and Top-down Approaches for This Report
    Figure 49. Data Triangulation
    Figure 50. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Bayer
F. HoffmannLa Roche
Regeneron
Novartis
Valeant
Pfizer
Frequently Asked Questions
Age Related Macular Degeneration (AMD) report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Age Related Macular Degeneration (AMD) report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Age Related Macular Degeneration (AMD) report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Agriculture Tools

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More